CRISPR Therapeutics AG
CRSP
•Stock Analysis$69.15
+0.00 (+0.00%)• Live
CRISPR Therapeutics AG Analysis Dashboard - Stock Analysis and Financial Metrics
Historical Prices
for CRISPR Therapeutics AG
Key Financial Metrics
for CRISPR Therapeutics AG
P/E Ratio
-9.25
Revenue Growth
-90.57%
EPS Growth
-123.71%
Market Cap
$3.59B
Dividend Yield
0.00%
Debt/Equity
0.12
ROIC
-23.22%
FCF Yield
-8.59%
View additional metrics
Valuation
P/B Ratio1.95
EV/Sales96.53
Financial Health
Current Ratio15.64
Return on Assets-17.80%
Analyst Recommendations
for CRISPR Therapeutics AG
37 analysts
Consensus: Buy
About
for CRISPR Therapeutics AG
Company Details
for CRISPR Therapeutics AG
Sector
Healthcare
Industry
Biotechnology
CEO
Samarth Kulkarni
Employees
393
Market Cap
6.29B
Exchange
NASDAQ Global Market
IPO Date
October 19, 2016
Website
www.crisprtx.comCIK
0001674416
ISIN
CH0334081137
CUSIP
H17182108
Country
CH
Balance Sheet
for CRISPR Therapeutics AG
Cash Flow Statement
for CRISPR Therapeutics AG
Income Statement
for CRISPR Therapeutics AG
News
No news available at the moment.